As of 3:47pm ET
| +0.29 / +4.35%|
The 8 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 16.50, with a high estimate of 27.00 and a low estimate of 12.00. The median estimate represents a +137.41% increase from the last price of 6.95.
The current consensus among 8 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.